#Visual Abstract Invasive Treatment Strategies Did Not Improve Outcomes for Older Patients with Myocardial Infarction
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Tag: cardiovascular death
#VisualAbstract: Targeting a Systolic Blood Pressure of <120 mmHg Reduces Vascular Events in High-risk Cardiovascular Patients
Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Artificial intelligence-aided analysis of retinal imaging may predict cardiovascular mortality
1. A model combining artificial intelligence-enabled analysis of retinal vascular images from a large database with several traditional risk factors ...
![The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]](https://www.2minutemedicine.com/wp-content/uploads/2013/05/web-cover-classics-with-logo-medicine-BW-small-jpg-350x250.jpg){kind=logo}
The CREDENCE trial: The effect of canagliflozin on renal function [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
The EAST-AFNET 4 trial: Early rhythm control therapy for atrial fibrillation [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
The VICTORIA trial: Transcatheter aortic-valve replacement versus surgery [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
Dapagliflozin efficacious and safe in treating heart failure
1. Dapagliflozin reduced the risk of worsening heart failure or cardiovascular death regardless of frailty status. 2. Dapagliflozin improved quality ...
#VisualAbstract: Rivaroxaban prophylaxis improves clinical outcomes in high-risk patients hospitalized with COVID-19
1. The primary efficacy outcome of symptomatic and asymptomatic venous thromboembolism was significantly lower in the rivaroxaban group (3.14%) compared ...